Ates O - Search Results

1

Platelet-to-Lymphocyte Ratio as an Indicator to Predict Decreased Carbon Monoxide Diffusion of the Lung in Patients with Testicular Cancer.

Karakaya S, Karadag I, Ozdilekcan C, Durmusoglu E, Ates O, Cakmak Oksuzoglu OB. Karakaya S, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2022 Mar;32(3):369-372. doi: 10.29271/jcpsp.2022.03.369. J Coll Physicians Surg Pak. 2022. PMID: 35148592

2

Clinical Outcomes and Prognostic Factors in HER-2 Positive Breast Cancer with Brain Metastasis: A Single-centre Experience.

Karakaya S, Karadag I, Ates O, Cakmak Oksuzoglu OB, Demirci U. Karakaya S, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2021 Feb;31(2):166-170. doi: 10.29271/jcpsp.2021.02.166. J Coll Physicians Surg Pak. 2021. PMID: 33645183

3

CROSS or FLOT in Distal Esophageal and Gastroesophageal Cancer.

Karadag I, Karakaya S, Ates O, Cakmak Oksuzoglu OB. Karadag I, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2021 Mar;31(3):326-329. doi: 10.29271/jcpsp.2021.03.326. J Coll Physicians Surg Pak. 2021. PMID: 33775025

4

Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data.

Ates O, Oksuzoglu OB, Aktas BY, Karadag I, Esen S, Karakaya S, Uncu D, Erol C, Gurbuz M, Yalcin B, Aksoy S. Ates O, et al. J BUON. 2021 Jul-Aug;26(4):1398-1404. J BUON. 2021. PMID: 34564997 Free article.

5

Clinicopathological features of non-carcinoid malignant epithelial appendix tumors and risk factors for recurrence, single-center experience.

Ates O, Aksel B, Karadag I, Karakaya S, Sunar V, Oksuzoglu OB. Ates O, et al. Indian J Cancer. 2024 Apr 1;61(2):305-311. doi: 10.4103/ijc.IJC_395_20. Epub 2022 Oct 12. Indian J Cancer. 2024. PMID: 36861708 Free article.

6

HIPEC in Ovarian Cancer: When and to Whom?

Ates O, Aksel B, Akkus MH, Oner I, Yuksel C, Dogan M. Ates O, et al. J Coll Physicians Surg Pak. 2023 Sep;33(9):1001-1005. doi: 10.29271/jcpsp.2023.09.1001. J Coll Physicians Surg Pak. 2023. PMID: 37691361

7

Efficacy and Safety of Combined Chemotherapy Regimens with Bevacizumab in Platinum-sensitive Ovarian Cancers.

Tay F, Buyukkor M, Ates O. Tay F, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2023 Sep;33(9):1006-1011. doi: 10.29271/jcpsp.2023.09.1006. J Coll Physicians Surg Pak. 2023. PMID: 37691362

8

Comparison of the Efficiency of Induction and Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer.

Buyukkor M, Tay F, Kurtulus A, Ates O. Buyukkor M, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2023 Oct;33(10):1141-1147. doi: 10.29271/jcpsp.2023.10.1141. J Coll Physicians Surg Pak. 2023. PMID: 37804020

9

Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.

Karatas F, Erdem GU, Sahin S, Aytekin A, Yuce D, Sever AR, Babacan T, Ates O, Ozisik Y, Altundag K. Karatas F, et al. Among authors: ates o. Breast. 2017 Apr;32:237-244. doi: 10.1016/j.breast.2016.05.013. Epub 2016 Jun 16. Breast. 2017. PMID: 27318645

10

Molecular subtypes in patients with inflammatory breast cancer; a single center experience.

Kertmen N, Babacan T, Keskin O, Solak M, Sarici F, Akin S, Arik Z, Aslan A, Ates O, Aksoy S, Ozisik Y, Altundag K. Kertmen N, et al. Among authors: ates o. J BUON. 2015 Jan-Feb;20(1):35-9. J BUON. 2015. PMID: 25778293 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters